Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal 1 receptor 65 pseudogene (VN1R65P) is a human genomic locus classified as a pseudogene belonging to the vomeronasal type-1 receptor (V1R) family[3][5][7][9]. The V1R family encodes chemosensory G protein-coupled receptors expressed in the vomeronasal organ of mammals, which are involved in pheromone detection and social chemical communication[6]. However, VN1R65P is annotated as a pseudogene in humans, meaning that it does not produce a functional protein product due to disabling mutations or truncations in its gene sequence[3][5][9]. As such, it has no established biological activity, functional interactions, or relevance as a therapeutic or diagnostic target. While V1R family members are functionally significant in some species, large portions of this family are non-functional (as pseudogenes) in humans, reflecting evolutionary loss of these chemosensory capabilities[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 1 receptor 65 pseudogene (VN1R65P).